In Finland, Kemira and IFF have completed construction of a “market-entry scale” industrial biobased polymer plant.
The unit is capable of producing unique renewable polymers for Kemira’s customers and is based on the patented Designed Enzymatic Biomaterial platform technology developed by IFF. The unit will be operated by Chemigate, a member of the Berner Group, and is located within Chemigate Ltd’s Finnamyl biorefinery in Kokemäki, Finland.
Kemira and IFF are also considering a full-scale DEB unit at IFF’s biorefinery site in Kotka, Finland. “We continue to receive increasing positive feedback from the market supporting the need for this new technology. We are excited to continue creating momentum for use in strategic markets such as paper and board packaging, and water treatment,” says Sampo Lahtinen, SVP Growth Accelerator, Kemira Oyj.